Evidence map›Paper›PMID 37927987›Full record

ArticleClinical case reports2023

Giant pilomatrix carcinoma of the scalp with intracranial extension: A case report.

Kenneth Mlay, Peter Shija, Marco Magwizi, Ezekiel G Karuga, Philbert Mtenga, Alex Mremi

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kenneth MlayDepartment of Otorhinolaryngology Kilimanjaro Christian Medical Centre Moshi Tanzania.
Peter ShijaDepartment of Otorhinolaryngology Kilimanjaro Christian Medical Centre Moshi Tanzania.
Marco MagwiziDepartment of Otorhinolaryngology Kilimanjaro Christian Medical Centre Moshi Tanzania.
Ezekiel G KarugaDepartment of Otorhinolaryngology Kilimanjaro Christian Medical Centre Moshi Tanzania.
Philbert MtengaDepartment of Otorhinolaryngology Kilimanjaro Christian Medical Centre Moshi Tanzania.
Alex MremiFaculty of Medicine Kilimanjaro Christian Medical University College Moshi Tanzania.ORCID https://orcid.org/0000-0001-7226-0168
Kilimanjaro Christian Medical Centre · TZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Key Clinical Message: A very rare skin cancer. Malignant variant of pilomatricoma. It is unique because of its highly aggressive behavior. Responds poorly to chemotherapy and radiotherapy. Treated with a wide surgical excision with safe margins. Abstract: Pilomatrix carcinoma is uncommon and locally aggressive tumor of the hair follicle matrix. It is a malignant variant of pilomatricoma. If left untreated for a long time may attain massive size and has the potential for distant spread. Only few cases with brain extension have been reported in the literature. Diagnosis of these tumors is established by histopathology. Although pilomatrixoma and pilomatrix carcinoma are well-recognized lesions, clinically they are frequently misdiagnosed as other skin conditions. The tumors respond poorly to chemotherapy and radiotherapy. Thus, recommended treatment is a wide surgical excision with safe margins. Herein, we report the case of a 39-year-old African woman with pilomatrix carcinoma of the scalp eroding the skull bone with intracranial extension.

Indexed as

case reportmalignant pilomatrixomapilomatrix carcinomarecurrenceskin cancerwide local excision

Identifiers

PMID37927987
PMCPMC10625130
OpenAlexW4388342618

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.